Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Nov 30, 2025 | (Q1)May 31, 2025 | (FY)Feb 28, 2025 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 94.37B | 3.86%95.64B | 2.91%377.42B | 4.03%95.98B | 3.16%92.09B | 4.45%366.74B | 3.94%94.41B | 4.74%90.8B | 5.03%92.26B | 4.11%89.28B |
| Cost of revenue | 67.66B | 4.66%69.16B | 3.20%268.63B | 4.63%68.23B | 3.33%66.08B | 3.78%260.29B | 3.46%66.54B | 3.66%64.58B | 3.56%65.21B | 4.47%63.95B |
| Gross profit | 26.71B | 1.83%26.49B | 2.19%108.79B | 2.59%27.75B | 2.72%26.01B | 6.14%106.45B | 5.11%27.87B | 7.50%26.21B | 8.76%27.05B | 3.23%25.32B |
| Operating expense | 24.24B | 28,388.10%23.76B | 1.89%94.73B | 1,585,766.67%47.57B | -425.00%-84M | 3.31%92.97B | 3.26%92.99B | 0 | -200.00%-3M | 71.43%-16M |
| Total other operating income | ---- | ---- | ---- | --0 | 425.00%84M | ---- | ---- | --0 | 200.00%3M | -71.43%16M |
| Operating profit | 2.48B | -89.56%2.72B | 4.30%14.06B | -173.24%-19.82B | 2.98%26.09B | 30.87%13.48B | -2.49%-65.12B | 7.50%26.21B | 8.76%27.06B | 3.06%25.34B |
| Net non-operating interest income (expenses) | 18M | 120.51%8M | 24.37%-90M | 40.00%-27M | 15.22%-39M | 38.02%-119M | 138.30%18M | 6.12%-46M | -2.27%-45M | 11.54%-46M |
| Non-operating interest income | --59M | 500.00%54M | 160.53%99M | 110.00%21M | 0.00%9M | -11.63%38M | 0.00%10M | -10.00%9M | -33.33%10M | 12.50%9M |
| Non-operating interest expense | --41M | -4.17%46M | 20.38%189M | -12.73%48M | -12.73%48M | -33.19%157M | -114.04%-8M | -6.78%55M | -6.78%55M | -8.33%55M |
| Net investment income | 2M | 0.00%16M | 14.29%16M | 75.00%7M | 0 | |||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 45M | 173.56%64M | 1.32%-896M | 32.31%-155M | -87M | -6.95%-908M | 32.15%-536M | -521.74%-143M | -1,045.00%-229M | 0 |
| Less:Restructuring and mergern&acquisition | ---- | ---- | -69.53%39M | ---- | ---- | 312.90%128M | 1,200.00%39M | ---- | ---- | ---- |
| Less:Other special charges | ---45M | -173.56%-64M | 2,500.00%104M | --8M | --87M | 103.05%4M | --0 | ---- | ---- | ---- |
| Less:Write off | --0 | ---- | -2.96%753M | ---- | ---- | -18.23%776M | -36.69%497M | 127.27%50M | ---- | ---- |
| Other non-operating income (expenses) | 9M | 324.00%106M | 32.35%180M | 358.33%110M | -26.47%25M | -15.00%136M | -32.10%55M | -42.50%23M | 14.29%24M | 88.89%34M |
| Income before tax | 2.55B | 2.18%2.9B | 5.24%13.27B | 4.47%3.27B | 17.56%2.84B | 33.62%12.61B | 31.12%4.29B | 70.94%2.77B | 35.17%3.13B | 8.49%2.42B |
| Income tax | 836M | -9.82%891M | -9.62%3.88B | 4.40%1.09B | 14.88%988M | 31.40%4.29B | 31.18%1.42B | 66.84%966M | 24.70%1.05B | 12.27%860M |
| Net income | 1.71B | 8.59%2.01B | 12.92%9.39B | 4.55%2.18B | 19.05%1.85B | 34.78%8.31B | 31.05%2.87B | 73.32%1.81B | 41.11%2.09B | 6.44%1.55B |
| Net income continuous operations | --1.71B | 8.59%2.01B | 12.92%9.39B | 4.50%2.18B | 19.04%1.85B | 34.79%8.31B | 31.09%2.87B | 73.22%1.81B | 41.11%2.09B | 6.51%1.56B |
| Noncontrolling interests | 0 | 0 | 0 | |||||||
| Net income attributable to the company | 1.71B | 8.59%2.01B | 12.92%9.39B | 4.55%2.18B | 19.05%1.85B | 34.75%8.31B | 31.05%2.87B | 73.32%1.81B | 41.01%2.09B | 6.44%1.55B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 1.71B | 8.59%2.01B | 12.92%9.39B | 4.55%2.18B | 19.05%1.85B | 34.75%8.31B | 31.05%2.87B | 73.32%1.81B | 41.01%2.09B | 6.44%1.55B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 53.73 | 8.52%63.03 | 12.81%294.51 | 4.41%68.43 | 18.92%58.08 | 34.69%261.06 | 30.97%89.99 | 73.26%56.69 | 40.98%65.54 | 6.41%48.84 |
| Diluted earnings per share | 53.72 | 0.00%58.06 | 12.90%294.45 | 4.52%68.42 | 19.00%58.06 | 34.73%260.8 | 31.01%89.91 | 73.32%56.64 | 40.99%65.46 | 6.46%48.79 |
| Dividend per share | 0 | 0 | 16.67%70 | 0 | 0 | 5.26%60 | 5.26%60 | 0 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |